Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Indian Immunologicals Limited

Tracked across 3 events · 115 articles · First seen Dec 27, 2025 · Last active Sep 05, 2026

Sentiment
-33
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 -60
Regulatory
Impact: Indian Immunologicals Limited is the manufacturer of the Abhayrab vaccine, which was found to have counterfeit batches circulating in India. The company proactively identified the anomaly and informed regulators, but the incident has led to a negative advisory from Australia, impacting public trust and the company's reputation.
Dec 27, 2025 · 15 articles
4 -40
Regulatory
Impact: The manufacturer of Abhayrab faces regulatory scrutiny and potential reputational damage from the flagged batch. This is the second counterfeit-related incident in two years, which could affect its market position and export business.
Sep 04, 2026 · 7 articles
4 0
Regulatory
Impact: Indian Immunologicals Limited is developing its own dengue vaccine candidate and is preparing for mid-stage trials, positioning itself as a future competitor.
Jul 20, 2026 · 93 articles
ERGEN INTELLIGENCE
Track Indian Immunologicals Limited live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.